Gubra
Business Services · Denmark · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Hørsholm Kongevej 11b, Korsholm, North D...Phone Number
+45 31522650Website
www.gubra.dkRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Gubra
Gubra specializes in high-end preclinical contract research and peptide-based drug discovery, focusing on metabolic and fibrotic diseases. Their services include advanced modeling and technologies for drug development, particularly in areas such as obesity, diabetes, and kidney diseases. Gubra partners with various organizations to enhance drug discovery and development, leveraging their expertise in peptide therapeutics. The company is committed to sustainability and invests in green initiatives to contribute to a more sustainable future.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gubra your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Gubra has new funding data
Check out if Gubra is spiking on competitors!
Product Launch: Get notified when Gubra launches new products
Check if Gubra has recently received funding, and reach out quickly before it becomes old news!
Gubra, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Gubra
Earning: See what the market has to say on Gubra recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Gubra had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Gubra
Find more new buyers
Company Profile Activity
Activity Insights
Gubra is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Gubra is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Gubra.
Gubra Tech Stack
A closer look at the technologies used by Gubra
See more technologies
Most Recent Scoops
Person-Based
Research & Development, Pharmaceuticals
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Gubra News & Media
Gubra re-elects board of directors - MedWatch
Monika Lessl will thus continue as chair of the Danish biotech company.Gubra recruits former Novo Nordisk director as new CTO - MedWatch
Gubra’s new chief technology officer was until recently senior director at Novo Nordisk.Denmark: Abbvie enters obesity field with license agreement with Gubra
Denmark: Abbvie enters obesity field with license agreement with GubraAbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity
Partnership marks AbbVie's entrance into the obesity field Agreement will enable the incorporation of GUB014295, an amylin peptide discovered and developed by Gubra, into AbbVie's global infrastructure for developing and commercializing therapies for patients in need NORTH CHICAGO, Ill....
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gubra
Sign Up For FreeTo access detailed company insights
Gubra specializes in high-end preclinical contract research and peptide-based drug discovery, focusing on metabolic and fibrotic diseases. Their services include advanced modeling and technologies for drug development, particularly in areas such as obesity, diabetes, and kidney diseases. Gubra partners with various organizations to enhance drug dis... Read More
